LEXICON PHARMACEUTICALS, INC. Supplemental Unemployment Benefits, Severance Benefits
LEXICON PHARMACEUTICALS, INC. (LXRX) had Supplemental Unemployment Benefits, Severance Benefits of $600.00 thousand as of 2025-06-30, per its 10-Q filed 2025-08-06.
Financial Statements › Notes › Compensation Related Costs
us-gaap:SupplementalUnemploymentBenefitsSeveranceBenefits · last filed 2026-03-05
- 2025-06-30: Supplemental Unemployment Benefits, Severance Benefits $600.00K.
- 2025-03-31: Supplemental Unemployment Benefits, Severance Benefits $1.10M.
- 2024-12-31: Supplemental Unemployment Benefits, Severance Benefits $8.80M.
- 2024-09-30: Supplemental Unemployment Benefits, Severance Benefits $1.50M.
| Period end | Supplemental Unemployment Benefits, Severance Benefits |
|---|---|
| 2025-06-30 | $600.00K 10-Q · filed 2025-08-06 |
| 2025-03-31 | $1.10M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $8.80M 10-K · filed 2026-03-05 |
| 2024-09-30 | $1.50M 10-Q · filed 2024-11-13 |
| 2023-12-31 | $700.00K 10-K · filed 2025-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |